2025 Policy Dialogue: Safeguarding Intellectual Property Rights & Public Health

Explore the intersection of intellectual property (IP) and the pharmaceutical sector at the upcoming 2025 Policy Dialogue: Safeguarding Intellectual Property Rights & Public Health: From Falsified/Counterfeit Medicines to Data Exclusivity, taking place in Istanbul on November 24, 2025.

This in-person event, hosted by INTA and the Association of Research-Based Pharmaceutical Companies (AIFD), brings together industry leaders, government officials, and legal experts for discussions on combating counterfeit medicines and the role of data exclusivity in supporting innovative pharmaceuticals.

Agenda:

2:00 pm – 2:05 pm | Welcome Remarks
Tat Louembe, International Trademark Association (INTA), Belgium
Uğur Aktekin, Gün + Partners, Türkiye

2:05 pm – 2:15 pm | Keynote Speech
Speaker TBD

2:15 pm – 3:15 pm | Combating Falsified/Counterfeit Medicines
Discussion on challenges posed by counterfeit pharmaceuticals, including customs enforcement, public health, interagency collaboration, and the role of IP in safeguarding medicine quality.

Moderator: Direnç Bada, Gün + Partners, Türkiye
Speakers:
Cenk Burak Altay, Customs Directorate of the Government of Türkiye
Seda Gunduz, Customs Enforcement, Smuggling and Intelligence Directorate of the Government of Türkiye

3:15 pm – 3:45 pm | Coffee Break
3:45 pm – 4:45 pm | Data Exclusivity and Broader IP Protection for Innovative Medicines

Panel discussion on how IP rights support innovation, the legal and regulatory framework in Türkiye, and the practical implications of exclusivity periods.

Moderator: Dicle Doğan, Gün + Partners, Türkiye
Speakers:
Gülbin Olgun Erbak, Johnson & Johnson, Türkiye
Özge Atılgan Karakulak, Gün + Partners, Türkiye

4:45 pm – 5:00 pm | Closing Remarks
INTA and AIFD representatives

5:00 pm – 6:00 pm | Networking Cocktail Reception